Flu A + B

RAMP® FLU A + B

The RAMP® Flu A + B test is a qualitative immunochromatographic test used for the detection of influenza A and B nucleoprotein antigens in nasal wash/aspirate, nasopharyngeal aspirate and nasopharyngeal swab specimens from symptomatic patients. It is an in vitro diagnostic test that aids in the rapid differential diagnosis of influenza viral infections in symptomatic patients.

Read more
RSV

RAMP® RSV

The RAMP® RSV test is a qualitative, immunochromatographic test used for the detection of Respiratory Syncytial Virus (RSV) F-protein antigens in nasal wash, nasopharyngeal aspirate and nasopharyngeal swab samples. It is an in vitro diagnostic test that aids in the rapid diagnosis of RSV infections in symptomatic patients 21 years of age and younger.

Read more
Procalcitonin

RAMP® Procalcitonin

The RAMP® Procalcitonin assay is a quantitative immunochromatographic test indicated for use as an in vitro diagnostic product used with a RAMP® instrument to measure levels of the prohormone procalcitonin (PCT) in human EDTA anticoagulated whole blood. The RAMP® Procalcitonin assay is intended to be used in conjunction with other laboratory findings and clinical assessments as an aid in the risk assessment of progression to severe sepsis and septic shock. 

Read more

Please contact Customer Support (1-888-591-5577 or 1-604-456-6010) to find out the products available for use in the country of interest.

1For use with the RAMP® 200.

2Uzzan et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006. 34:1996-2003

3Schuetz et al. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Medicine 2011. 9:107-15

4Kumar et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006. 34:1589-1596.

5Shorr et al. Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs? Crit Care Med 2007. 35(5):1257-1262.